LifeMD(US:LFMD)2023-11-08 23:51Financial Performance & Guidance - LifeMD expects full year 2023 consolidated net revenue to be between $148 million and $149 million, representing a 24%-25% increase compared to the $119 million in 2022[17, 76] - The company anticipates consolidated adjusted EBITDA of $10 million to $11 million for 2023, a significant improvement from the $(15) million in 2022[1, 2, 17] - Gross margins are projected to reach 87% in 2023, up from 84% in 2022[17] - WorkSimpli is expected to generate $15 million to $18 million in adjusted EBITDA for full year 2023[73] Business Highlights - LifeMD's virtual care platform has facilitated over 800,000 virtual consults[23] - The company has approximately 207,000 active patients[23] - WorkSimpli has over 170,000 subscribers and is available in approximately 20 languages globally[73] - LifeMD maintains over 73% ownership in WorkSimpli, representing potential future exit value exceeding $100 million[36, 80] Strategic Focus - LifeMD's strategy focuses on scaling high-value revenue streams through virtual primary care, RexMD, and partnerships[53, 78]